|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
is crucial for the development of mast-cell dependent colitis in mice
1 Pharmacology and Pathophysiology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
2 Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Pharmacology and Pathophysiology, United States
* To whom correspondence should be addressed. E-mail: a.rijnierse{at}pharm.uu.nl.
Inflammatory bowel disease (IBD) describes chronic inflammatory conditions of the gastro-intestinal tract and tumor necrosis factor alpha (TNF
) plays a pivotal role in mediating the response. The pro-inflammatory cytokine TNF
is rapidly released by mast cells after degranulation. In the present study we hypothesized TNF
to be an important player in our recently described mast cell-dependent murine model for IBD. The effect of neutralizing anti-TNF
MAb was studied on colonic hypersensitivity in mice induced by skin application of dinitrofluorobenzene (DNFB) followed by intrarectal challenge with dintrobenzene sulfonic acid (DNS). Features of the colonic hypersensitivity response include diarrhea, mast cell infiltration and activation, infiltration of inflammatory cells in the colon, colonic patch hypertrophy and increased mast cell-derived TNF
levels in the colon. Anti-TNF
MAb could effectively abrogate diarrhea in DNFB-sensitized mice 72h after challenge. The number of colonic patches and total tissue damage score were reduced by anti-TNF
MAb treatment in DNFB-sensitization 72h after challenge. Mast cell infiltration and activation remained unaffected by neutralizing anti-TNF
MAb. Treatment with the corticosteroid dexamethasone, a frequently used therapeutic treatment in IBD, resulted in reduction of diarrhea, cellular infiltration and total tissue damage score in the same extent as anti-TNF
MAb. Additionally, dexamethasone treatment could also reduce total TNF
levels in the colon, mast cell number and mast cell activation in both vehicle- and DNFB-sensitized mice 72h after challenge. These findings suggest that TNF
can play an instrumental role in causing inflammatory responses in the present murine model for IBD downstream from mast cell activation.
This article has been cited by other articles:
![]() |
H. Chen, H. Xu, J. Dong, J. Li, and F. K. Ghishan Tumor necrosis factor-alpha impairs intestinal phosphate absorption in colitis Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G775 - G781. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, H. Chen, J. Dong, J. Li, R. Chen, J. K. Uno, and F. K. Ghishan Tumor necrosis factor-{alpha} downregulates intestinal NHE8 expression by reducing basal promoter activity Am J Physiol Cell Physiol, March 1, 2009; 296(3): C489 - C497. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Reuter, A. Heinz, M. Sieren, R. Wiewrodt, E. W. Gelfand, M. Stassen, R. Buhl, and C. Taube Mast cell-derived tumour necrosis factor is essential for allergic airway disease Eur. Respir. J., April 1, 2008; 31(4): 773 - 782. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |